News Diagnostics & Imaging Skin Cancers Pathology

Weekly News Brief: November 9–13, 2026

November 13, 2026 By ASCO AI Staff 3 min watch
Share Share via Email Share on Facebook Share on LinkedIn Share on Twitter

To catch up on all of the news from this past week, listen to our weekly news brief for the week of November 9–13, 2026.

This week’s brief covers an FDA Breakthrough Device designation for AI skin cancer pathology, a three-marker machine learning risk score in metastatic castration-resistant prostate cancer, and a digital pathology model that infers the 70-gene MammaPrint score from routine slides.

Disclaimer: This newscast was generated with the assistance of AI tools and avatars. All content is reviewed and approved by the editorial staff of ASCO AI in Oncology. Contact us with any questions. 

The ideas and opinions expressed in ASCO AI in Oncology do not necessarily reflect those of Conexiant or ASCO. The mention of any company, product, service, or therapy should not be construed as an endorsement of any kind. Conexiant and ASCO assume no responsibility for any injury or damage to persons or property arising out of or related to any use of material contained in this publication or to any errors or omissions.

Related Content